Investor FAQ

Here are answers to some of our frequently asked questions.

What are the international and German securities code numbers (ISIN/WKN) for Biosilu Healthcare AG shares?
The international securities identification number (ISIN) is DE000A0SMU87, and the German securities code number (WKN) is A0SMU8.

Where are the Biosilu Healthcare AG shares being traded?
Biosilu Healthcare AG shares are traded on the Munich Stock Exchange (Freiverkehr) in Germany.

What type of shares has Biosilu Healthcare AG issued?
The shares of Biosilu Healthcare AG are ordinary bearer shares with no par value, each representing a notional value of €1.00 and with full dividend rights from January 1, 2015.

When and in what amount will there be dividend payouts?
Biosilu Healthcare AG currently intends to retain all available funds and future earnings, if any, to further develop the global operations and create a sustainable growing shareholder value. Biosilu Healthcare AG does not pay a dividend at present but may do so in the future.

On which market are the Biosilu Healthcare AG shares listed?
Biosilu Healthcare AG is listed on the regulated unofficial market (Freiverkehr) of the Munich Stock Exchange.

How is the executive board of Biosilu Healthcare comprised?
According to the articles of incorporation of Biosilu Healthcare AG, the executive board (Vorstand) may consist of one or several members. Currently Klaus K. Wilgenbus is the Chief Executive Officer of the executive board.

How is the supervisory board of Biosilu Healthcare comprised?
The supervisory board (Aufsichtsrat) is comprised of the following members:
Dr. Stefan Elsser (Chairman)
Dr. Simon Nebel (Vice Chairman)
Dr. Bernd Hartmann

What is the fiscal year of Biosilu Healthcare AG?
The fiscal year of Biosilu Healthcare AG is identical to the calendar year, beginning on January 1 and ending on December 31.

Who is the public auditor of Biosilu Healthcare AG?
The annual general meeting appointed AOIS GmbH, Berlin, Germany, as the company’s certified public auditor for the fiscal year 2014.

Where can I find the articles of incorporation?
The articles of incorporation can in the section "Stock Information".

To what disclosure requirements is amp biosimilars AG subject?
As a company listed within the regulated unofficial Market of the Munich Stock Exchange, Biosilu Healthcare AG is not subject to certain legal disclosure requirements such as quarterly financial reporting or ad hoc disclosures. Its disclosure obligations are specified in the General Business Conditions for the regulated unofficial Market on the Munich Stock Exchange.

What accounting standards does the company follow?
The annual financial statements of Biosilu Healthcare AG are prepared in accordance with the requirements of German statutory accounting (HGB).

Where can I find the current financial report?
The financial report is available on the “Financial Information” page of this Investor Relations section.

What emphasis does Biosilu Healthcare AG place on Corporate Governance?
Biosilu Healthcare AG places great importance on adhering to the highest standards of corporate governance. As a company listed in the regulated unofficial segment of the Munich Stock Exchange, Biosilu Healthcare AG has no obligation under sec. 161 of the German Stock Corporation Act (Aktiengesetz) to make a declaration regarding the extent of its compliance with the recommendations of the German Corporate Governance Code. The management and supervisory board are, however, considering whether to publish such a declaration of compliance in the future.

When was the Biosilu Healthcare AG listing on the stock exchange?
Shares of Biosilu Healthcare AG have been listed on the Munich Stock Exchange since the 1st of April 2015.

Who are the shareholders of Biosilu Healthcare AG?
The company’s largest shareholder is Singularity Capital AG. Other shareholders include key employees, institutional investors (e.g. investment companies), and strategically important partners.

How many shares of Biosilu Healthcare AG are outstanding?
There are currently 2,075,000 common shares of Biosilu Healthcare AG outstanding, in the form of bearer shares (Inhaber-Stammaktien).

Who can I call if I have further questions?
Biosilu Healthcare AG's Investor Relations department is happy to answer any shareholder questions. Please contact us via the Investor Relation Contact section of this website.